Chien-Fen Chen

Title: Innovations by Chien-Fen Chen in Neurodegenerative Disorder Treatments

Introduction

Chien-Fen Chen is an accomplished inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative disorders. With a total of two patents to his name, Chen's work focuses on innovative oral dosage formulations that enhance drug delivery and efficacy.

Latest Patents

Chen's latest patents include an oral dosage formulation containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders. This formulation features an acetylcholinesterase inhibitor (AChEI) that releases more than 80% of the drug within 60 minutes, alongside memantine, which has a sustained-release profile allowing for over 80% dissolution within 12 hours. Another patent details a method for treating patients with central nervous system disorders using this oral dosage formulation, ensuring optimal blood levels of both the AChEI and memantine over specified time frames.

Career Highlights

Chien-Fen Chen is currently associated with Center Laboratories, Inc., where he continues to innovate in the pharmaceutical sector. His work is pivotal in developing effective treatments for conditions that affect millions worldwide.

Collaborations

Chen collaborates with notable colleagues, including Chuen-Lin Din and Huai-Cheng Lee, who contribute to the research and development efforts at Center Laboratories, Inc.

Conclusion

Chien-Fen Chen's innovative approaches to drug formulation and treatment methods represent a significant advancement in the management of neurodegenerative disorders. His contributions are vital in improving patient outcomes and enhancing the quality of life for those affected by these conditions.